Tag: (NASDAQ:ONCE)

July 22, 2019

What is Genetics Investing?

Genetics investing drives research that may ultimately prevent major illnesses. That makes it one of the most important life science...
July 18, 2019

5 Gene Therapy Stocks for Investors

What gene therapy companies should be on investors' radar? Here are five companies developing a wide range of gene therapy...
May 2, 2019

FDA to Ramp Up Efforts in Gene Therapy Development

The number of gene therapy products in development is growing, and the FDA is advancing its efforts to move these...
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
December 19, 2018

Biotech Outlook 2019: Will the Pressure Continue?

With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in...
November 23, 2018

European Commission Approves Spark Therapeutics’ LUXTURNA

Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced...
October 30, 2018

Spark Therapeutics Presents Three Post-hoc Analyses from Phase 3 Clinical Trial of LUXTURNA

Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced...